Volans Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.47 M
- Company Age 11 Year, 25 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.00 M
- Revenue Growth 55.63%
- Profit Growth 53.93%
- Ebitda 34.89%
- Net Worth 213.37%
- Total Assets 64.84%
About Volans Life Sciences
Volans Life Sciences Private Limited (VLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 January 2014 and has a history of 11 years. Its registered office is in Aurangabad, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.47 M.
The company currently has active open charges totaling ₹1.00 M.
Dayanand Patil and Abdul Samad serve as directors at the Company.
Company Details
- Location Aurangabad, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231MH2014PTC252712
- Company No.
252712
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Volans Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dayanand Patil  | Director | 31-Jan-2014 | Current |
| Abdul Samad | Director | 05-Apr-2021 | Current |
Financial Performance of Volans Life Sciences.
Volans Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 55.63% increase. The company also saw a substantial improvement in profitability, with a 53.93% increase in profit. The company's net worth Soared by an impressive increase of 213.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Volans Life Sciences?
In 2020, Volans Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Feb 2019 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Volans Life Sciences?
Volans Life Sciences has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Volans Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Volans Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
